Know Your ADCs: Nursing Perspectives on Antibody-Drug Conjugates Targeting TROP-2 in Solid Tumors

Get up to date on TROP2-targeted ADCs across tumor types with this comprehensive nursing program featuring an on-demand webcast and downloadable slidesets from a live symposium along with an expert-authored commentary.

Share

Program Content

Activities

TROP2 ADC Overview
Antibody‒Drug Conjugates and Their Role in TROP2-Expressing Tumors
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2023

TROP2 ADC Efficacy
Clinical Data on TROP2-Targeting ADCs in Breast, Urothelial, and Lung Cancers
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2023

TROP2 ADC Toxicity
Identification and Management of Adverse Events With TROP2-Targeting ADCs
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 28, 2023

Activities

Nursing Perspectives TROP2 ADCs
Know Your ADCs: Nursing Perspectives on Antibody–Drug Conjugates Targeting TROP2 in Solid Tumors
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 22, 2023

Expires: June 21, 2024

Activities

TROP2 ADCs for Oncology Nurses
TROP-2–Targeting Antibody–Drug Conjugates: Perspectives for the Oncology Nurse Specialist
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2023

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Gilead Sciences, Inc. 

Gilead Sciences, Inc.